[{"Assets_0_Q2_USD":1457130000.0,"CommonStockSharesConverted_0_Q2_shares":45539000.0,"CommonStockSharesOutstanding_0_Q2_shares":45539000.0,"EarningsPerShareBasic_1_Q2_USD":-1.73,"EarningsPerShareBasic_2_Q2_USD":-3.41,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-128837000.0,"NetIncomeLossConverted_1_Q2_USD":-70898000.0,"NetIncomeLossConverted_2_Q2_USD":-139611000.0,"RevenuesConverted_1_Q2_USD":16716000.0,"RevenuesConverted_2_Q2_USD":23548000.0,"StockholdersEquity_0_Q2_USD":1200019000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170802"}]